Methylenolactocin, a novel antitumor antibiotic from Penicillium sp.
Authors:
- Masahira NakagawaMNMasahira Nakagawa
- Akira HirotaAHAkira Hirota
- Mitsuru NakayamaMNMitsuru Nakayama
- 1 January 1988
- journal article
- research article
- Published by Japan Antibiotics Research Association in The Journal of Antibiotics
- Vol. 41 (6) , 751-758
Abstract
A novel antitumor antibiotic, methylenolactocin, was isolated from the culture filtrate of a new isolate of fungus identified as Penicillium sp. The fermentation yield reached about 100 mg per liter of the broth. Methylenolactocin has the molecular formula of C11H16O4 and possess an exomethylene lactone structure. Its structure was determined to be 3-carboxy-2-methylene-4-nonanolide by spectroscopic data. It is active against some Gram-positive bacteria and it prolongs the life span of mice inoculated with Ehrlich carcinoma.Keywords
This publication has 5 references indexed in Scilit:
- Anti-tumor Activities of Some Lichen Products and Their Degradation ProductsYAKUGAKU ZASSHI, 1980
- Potential antitumor agents. Synthesis, reactivity, and cytotoxicity of .alpha.-methylene carbonyl compoundsJournal of Medicinal Chemistry, 1978
- Direct methods for .alpha.-methylene lactone synthesis using itaconic acid derivativesThe Journal of Organic Chemistry, 1976
- Canadensolide - an antifungal metabolite of penicillium canadenseTetrahedron Letters, 1968
- PROMOTING ACTIVITY OF TERPENIC LACTONES IN PHASEOLUS ROOTING AND THEIR REACTIVITY TOWARD CYSTEINE1Plant and Cell Physiology, 1967